Leap Therapeutics (LPTX) Announces Pact with Merck KGaA and Pfizer (PFE) to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors
Tweet Send to a Friend
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced it has entered into a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
